Compare SPHL & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPHL | VVOS |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | Singapore | United States |
| Employees | 73 | N/A |
| Industry | Homebuilding | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 5.7M |
| IPO Year | N/A | 2020 |
| Metric | SPHL | VVOS |
|---|---|---|
| Price | $2.59 | $0.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 191.7K | ★ 321.3K |
| Earning Date | 05-12-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,443,000.00 |
| Revenue This Year | N/A | $69.66 |
| Revenue Next Year | N/A | $48.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.05 |
| 52 Week Low | $0.35 | $0.38 |
| 52 Week High | $25.11 | $5.69 |
| Indicator | SPHL | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 45.46 | 36.61 |
| Support Level | $2.47 | $0.38 |
| Resistance Level | $2.74 | $0.55 |
| Average True Range (ATR) | 0.25 | 0.03 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 10.45 | 32.16 |
Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.